By marrying pharmacology with behavior change, we can resolve the adherence dilemma that has plagued real-world use of these drugs
Could GLP-1 Drugs Lower Epilepsy Risk in People with Diabetes
Get expert, physician-supervised weight loss in Anthem, Surprise, Phoenix, Peoria, Glendale, Scottsdale and surrounding areas
Recently, the TRIAL study demonstrated a lower incidence of death from renal causes, initiation of long-term renal replacement therapy (dialysis or transplant), persistent eGFR below 15 mL per minute per 1.73 m 2 , persistent 50% reduction in eGFR compared to baseline, and initiation of persistent macroalbuminuria in patients treated with semaglutide compared to placebo 47
Theres a reported 40-50% reduction of opioid and alcohol intoxication in people with a history of related disorders and there are phase 2 trials showing reductions in alcohol use and opioid cravings
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes